Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024

By sjmartinez • April 10, 2025

Lewis NM, Harker EJ, Cleary S, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Halasa NB, Lauring AS, Martin ET, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Duggal A, Felzer JR, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Ferguson SAN, Mosier J, Qadir N, Chang SY, Ginde AA, Zepeski A, Mallow C, Harris ES, Johnson NJ, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Surie D, Dawood FS, Ellington S, Self WH. Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024. J Infect Dis. 2025 Apr 8:jiaf185. doi: 10.1093/infdis/jiaf185. Epub ahead of print. PMID: 40198276.

Tags: Hospitalization, Publications, Pulmonary, Critical Care & Sleep Medicine, seasonal influenza, severe influenza, vaccine effectiveness, waning

Nuclear mechanobiology: a brief history and five unresolved questions

Lammerding J, Eeftens J, Gundersen GG, King MC, Lele TP, Li S, Luxton G W G, Medalia O, Piel M, Roca-Cusachs P, Renkawitz J, Roux[...]

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE

Rugo HS, Tolaney SM, Chan N, Borges G, Yerushalmi R, Sharifi MN, McHayleh W, Beck T, Vidula N, Hamilton E, Rinn KJ, O'Shaughnessy J, Curigliano[...]